Dexilant - 64764-171-90 - (dexlansoprazole)

Alphabetical Index


Drug Information of Dexilant

Product NDC: 64764-171
Proprietary Name: Dexilant
Non Proprietary Name: dexlansoprazole
Active Ingredient(s): 30    mg/1 & nbsp;   dexlansoprazole
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Dexilant

Product NDC: 64764-171
Labeler Name: Takeda Pharmaceuticals America, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022287
Marketing Category: NDA
Start Marketing Date: 20100412

Package Information of Dexilant

Package NDC: 64764-171-90
Package Description: 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-90)

NDC Information of Dexilant

NDC Code 64764-171-90
Proprietary Name Dexilant
Package Description 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-90)
Product NDC 64764-171
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name dexlansoprazole
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20100412
Marketing Category Name NDA
Labeler Name Takeda Pharmaceuticals America, Inc.
Substance Name DEXLANSOPRAZOLE
Strength Number 30
Strength Unit mg/1
Pharmaceutical Classes Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]

Complete Information of Dexilant


General Information